Nikolas K Haass

20PUBLICATIONS

90CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyStructural properties of condensed matterSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 10, 2026

S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers.

|Apr 07, 2026

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Zhen Zeng, Anastasia Gandini, Rituparna Bhatt

|Mar 28, 2026

The Emerging Melanoma Management: Historical Perspective to Future Directions.

Shin Yee Hui, Rohit Jain, Nikolas K Haass

|Dec 18, 2024

The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD models.

Sanket B Raut, Fanny Joly, Nikolas K Haass

|Aug 19, 2024

Compression-dependent microtubule reinforcement enables cells to navigate confined environments.

Robert J Ju, Alistair D Falconer, Christanny J Schmidt

|Dec 13, 2023

Formation and Growth of Co-Culture Tumour Spheroids: New Compartment-Based Mathematical Models and Experiments.

Ryan J Murphy, Gency Gunasingh, Nikolas K Haass

Pageof 4

Frequent Collaborators

Matthew Simpson

Ryan J Murphy

Dajiang Guo

Shweta Tikoo

Brian Gabrielli

Alexander P Browning

Wolfgang Weninger

Samantha J Stehbens

J Uitto

Q Li

Frequent Collaborators

Matthew Simpson

Ryan J Murphy

Dajiang Guo

Shweta Tikoo